title: Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone.
authors.forename: C J
authors.initials: CJ
authors.lastname: Gibbs
authors.forename: A
authors.initials: A
authors.lastname: Joy
authors.forename: R
authors.initials: R
authors.lastname: Heffner
authors.forename: M
authors.initials: M
authors.lastname: Franko
authors.forename: M
authors.initials: M
authors.lastname: Miyazaki
authors.forename: D M
authors.initials: DM
authors.lastname: Asher
authors.forename: J E
authors.initials: JE
authors.lastname: Parisi
authors.forename: P W
authors.initials: PW
authors.lastname: Brown
authors.forename: D C
authors.initials: DC
authors.lastname: Gajdusek
mesh_terms: D000328:Adult; D000818:Animals; D001921:Brain / Q000382:microbiology* / Q000648:ultrastructure; D001923:Brain Chemistry; D007562:Creutzfeldt-Jakob Syndrome / Q000378:metabolism / Q000382:microbiology / Q000473:pathology / Q000635:transmission*; D006224:Cricetinae; D004340:Drug Contamination; D004591:Electrophoresis, Polyacrylamide Gel; D013006:Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008854:Microscopy, Electron; D009419:Nerve Tissue Proteins / Q000032:analysis; D018622:PrP 27-30 Protein; D011328:Prions / Q000032:analysis
chemical_list: D009419:Nerve Tissue Proteins; D011328:Prions; D018622:PrP 27-30 Protein; D013006:Growth Hormone